1. Home
  2. YEXT vs YDES Comparison

YEXT vs YDES Comparison

Compare YEXT & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

HOLD

Current Price

$4.91

Market Cap

981.0M

Sector

Technology

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$11.33

Market Cap

894.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
YEXT
YDES
Founded
2006
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
981.0M
894.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
YEXT
YDES
Price
$4.91
$11.33
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$8.88
N/A
AVG Volume (30 Days)
1.4M
42.9K
Earning Date
03-04-2026
09-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$447,666,000.00
$510,360.00
Revenue This Year
$8.66
N/A
Revenue Next Year
$4.77
N/A
P/E Ratio
$8,361.77
N/A
Revenue Growth
9.46
45.76
52 Week Low
$4.67
$5.30
52 Week High
$9.20
$31.00

Technical Indicators

Market Signals
Indicator
YEXT
YDES
Relative Strength Index (RSI) 11.29 50.48
Support Level $4.75 $10.56
Resistance Level $7.94 $12.00
Average True Range (ATR) 0.25 0.77
MACD -0.26 -0.03
Stochastic Oscillator 4.86 61.34

Price Performance

Historical Comparison
YEXT
YDES

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: